Cellworks Group Inc
PrivateLast Round
Strategic
Jan 9, 2023
Est. Valuation
$62M
Total Funding Raised
$53.5M
Company Overview
Cellworks Group Inc operates in Healthcare & Life Sciences and is based in South San Francisco, California. Its latest recorded funding round was a Strategic round in January 2023.
Cellworks Group Inc is a biotechnology company that provides a biosimulation platform designed to predict therapy response for individual patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellworks Group Inc Comparables
Compare Cellworks Group Inc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nova In Silico | 84% | |
| QuantHealth | 84% | |
| VeriSIM Life | 81% |
For institutional investors. Book with your work email.
Cellworks Group Inc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 9, 2023 | ||||
| Series C | Jun 30, 2020 | ||||
| Series B | Dec 26, 2012 | ||||
| Series B | Oct 1, 2012 | ||||
| Series A | May 11, 2012 | ||||
Series A Extension | Mar 6, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cellworks Group Inc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agilent Ventures | Series B, Series A, Strategic |
| Sequoia Capital | Series A, Series B, Series C, Strategic |
| Bering Capital | Series B, Series A |
| Artiman | Series B, Series A, Series C, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 30, 2020
$15.5M round with Sequoia Capital and UnitedHealth Group.
- Dec 26, 2012
$13M round with Sequoia Capital and Artiman.
For institutional investors. Book with your work email.
Cellworks Group Inc Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellworks Group Inc's valuation, stock price, and market status.
Is Cellworks Group Inc a public or private company?
Cellworks Group Inc is a private company.
What is the current stock price of Cellworks Group Inc?
Cellworks Group Inc is a private company, so its shares have no public market price. Caplight tracks Cellworks Group Inc's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellworks Group Inc worth (valuation)?
Cellworks Group Inc's valuation is estimated at $62.0M based on funding round data.
Can I buy Cellworks Group Inc stock?
Cellworks Group Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellworks Group Inc's last funding round?
Cellworks Group Inc's most recent funding round was Strategic on January 9, 2023.
Who are the main investors in Cellworks Group Inc?
Key investors in Cellworks Group Inc include Sequoia Capital.
Will Cellworks Group Inc IPO soon?
No public IPO plans have been announced for Cellworks Group Inc.
How can I track Cellworks Group Inc secondary market activity?
Caplight tracks bids, offers, and trades in Cellworks Group Inc's shares on secondary markets.